Keith Katkin Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Keith Katkin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Keith Katkin. Keith Katkin is a Sr. V.P. of Sales & Marketing in AVANIR PHARMACEUTICALS, INC. ($AVNR) and a Director in RIGEL PHARMACEUTICALS INC ($RIGL) and a Director in Carbylan Therapeutics, Inc. ($CBYL) and a in Syndax Pharmaceuticals Inc ($SNDX) and a Director in Novus Therapeutics, Inc. ($NVUS) and a PEO;CEO-Urovant Sciences,Inc. in Urovant Sciences Ltd. ($UROV) and a PEO;CEO/Urovant Sciences, Inc. in Urovant Sciences Ltd. ($UROV).
Address: 11388 SORRENTO VALLEY ROAD, SUTIE 200 SAN DIEGO 92121 CA
Companies in which Keith Katkin is an Insider
AVANIR PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith Katkin: Sr. V.P. of Sales & Marketing
Holdings: 60,100 shares
Latest Transaction: Dec 14 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Eledon Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith Katkin: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 15 2020
$ELDN Market Capitalization: $20.25M
$ELDN Previous Close: $0.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KalVista Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith Katkin: Director
Holdings: 0 shares
Latest Transaction: Aug 05 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RIGEL PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith Katkin: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 15 2020
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syndax Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith Katkin:
Holdings: 16,000 shares
Current Value: $139,040
Latest Transaction: Feb 05 2021
$SNDX Market Capitalization: $163.37M
$SNDX Previous Close: $8.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Urovant Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith Katkin: PEO;CEO/Urovant Sciences, Inc., PEO;CEO-Urovant Sciences,Inc.
Holdings: 379,680 shares
Latest Transaction: Feb 21 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Keith Katkin
Sentiment: All, AVNR, ELDN, KALV, RIGL, SNDX, UROV
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Katkin Keith | Grant | A | 0.00 | 16,000 | 0 | 16,000 | 0 to 16 K | |
| Sep 15 2020 | NVUS | Novus Therapeutics ... | Katkin Keith | Director | Option Exercise | A | 500.00 | 5,907 | 2,953,500 | 5,907 | |
| May 15 2020 | RIGL | RIGEL PHARMACEUTIC ... | Katkin Keith | Director | Option Exercise | A | 1.77 | 55,000 | 97,075 | 55,000 | |
| May 15 2020 | RIGL | RIGEL PHARMACEUTIC ... | Katkin Keith | Director | Option Exercise | A | 1.77 | 55,000 | 97,075 | 55,000 | |
| Feb 21 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Option Exercise | M | 3.86 | 180,000 | 694,800 | 701,254 | |
| Feb 21 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Sell | J | 13.08 | 75,212 | 983,773 | 199,680 | 274.9 K to 199.7 K (-27.36 %) |
| Feb 21 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Payment of Exercise | F | 13.08 | 104,788 | 1,370,627 | 274,892 | 379.7 K to 274.9 K (-27.60 %) |